✦ LIBER ✦

Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)

✍ Scribed by M.F. Aberle; C. Bachier; F.C. Lemaistre; P.J. Shaughnessy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral valganciclovir as preemptive therap

✍ Katsuto Takenaka; Tetsuya Eto; Koji Nagafuji; Kenjiro Kamezaki; Yayoi Matsuo; Go 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 215 KB

Valganciclovir for the prophylaxis of ea

✍ C. Bachier; P. Shaughnessy; D. Wall; M. Grimley; G. Carrum; C. Freytes; N. Calla 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Oral valganciclovir is safe and effectiv

✍ E. Ayala; J. Greene; R. Sandin; J. Perkins; T. Field; C. Tate; S.C. Goldstein; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Initial low-dose valganciclovir as a pre

✍ Takenaka, Katsuto; Nagafuji, Koji; Takase, Ken; Kamimura, Tomohiko; Mori, Yasuo; 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 515 KB

Valganciclovir is safe and effective as

✍ Ayala, E; Greene, J; Sandin, R; Perkins, J; Field, T; Tate, C; Fields, K K; Gold 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Pre-transplant cytomegalovirus (CMV) ser

✍ B. George; N. Pati; N. Gilroy; M. Ratnamohan; G. Huang; I. Kerridge; M. Hertzber 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB